Nomura Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.6M Buy
190,227
+58,445
+44% +$12.8M 0.11% 203
2025
Q1
$29.5M Sell
131,782
-8,006
-6% -$1.79M 0.09% 236
2024
Q4
$45.8M Buy
139,788
+9,443
+7% +$3.09M 0.14% 167
2024
Q3
$39.1M Buy
130,345
+23,850
+22% +$7.16M 0.12% 192
2024
Q2
$35.1M Sell
106,495
-39
-0% -$12.8K 0.12% 181
2024
Q1
$42.2M Buy
106,534
+19,496
+22% +$7.71M 0.15% 152
2023
Q4
$30.6M Sell
87,038
-1,129
-1% -$398K 0.13% 195
2023
Q3
$33.1M Buy
88,167
+12,673
+17% +$4.76M 0.16% 159
2023
Q2
$28.9M Sell
75,494
-9,836
-12% -$3.76M 0.13% 181
2023
Q1
$29.6M Buy
85,330
+12,575
+17% +$4.36M 0.16% 150
2022
Q4
$17.1M Buy
72,755
+17,237
+31% +$4.06M 0.1% 230
2022
Q3
$13.7M Buy
55,518
+12,033
+28% +$2.96M 0.09% 259
2022
Q2
$13.1M Buy
43,485
+6,909
+19% +$2.09M 0.08% 259
2022
Q1
$15M Buy
36,576
+1,778
+5% +$730K 0.08% 252
2021
Q4
$16.3M Sell
34,798
-413
-1% -$194K 0.08% 236
2021
Q3
$14.9M Buy
35,211
+517
+1% +$219K 0.08% 234
2021
Q2
$12.5M Buy
34,694
+4,396
+15% +$1.58M 0.07% 273
2021
Q1
$8.54M Buy
30,298
+9,868
+48% +$2.78M 0.05% 323
2020
Q4
$5.79M Buy
20,430
+926
+5% +$262K 0.04% 386
2020
Q3
$5.36M Buy
19,504
+123
+0.6% +$33.8K 0.04% 358
2020
Q2
$4.4M Buy
19,381
+4,791
+33% +$1.09M 0.04% 385
2020
Q1
$2.22M Buy
14,590
+2,810
+24% +$428K 0.02% 478
2019
Q4
$1.77M Buy
11,780
+7,600
+182% +$1.14M 0.02% 657
2019
Q3
$593K Sell
4,180
-4,060
-49% -$576K 0.01% 853
2019
Q2
$1.03M Hold
8,240
0.01% 770
2019
Q1
$908K Hold
8,240
0.01% 777
2018
Q4
$808K Buy
+8,240
New +$808K 0.01% 747
2018
Q3
Sell
-11,240
Closed -$1.12M 1035
2018
Q2
$1.12M Hold
11,240
0.01% 714
2018
Q1
$992K Buy
+11,240
New +$992K 0.01% 742
2017
Q1
Sell
-240
Closed -$20K 1349
2016
Q4
$20K Buy
+240
New +$20K ﹤0.01% 1348